Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) CEO Phillip L’Huillier talked with Proactive's Stephen Gunnion about the company's latest clinical and...
IXICO PLC (LSE:IXI, OTC:PHYOF) imaging platform upgrade and two technology partnerships support...
AstraZeneca PLC (LSE:AZN, NYSE:AZN), the FTSE 100 pharmaceuticals group, has received fresh...
Drug repurposing model reduces risk and capital required Working to develop Ifenprodil for...
JP Morgan sees meaningful but price-sensitive growth potential for GLP-1 medicines, with...
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) CEO Phillip L’Huillier talked with Proactive's Stephen Gunnion about the company's latest clinical and regulatory progress, including FDA RMAT designation for its lead melanoma treatment, inzitagene plasmivec (iSCIB1+), updated survival data and...